Evidence map›Paper›PMID 38686918›Full record

ArticleBiotechnology and bioengineering2024

Rapid spectrophotometric detection for optimized production of landomycins and characterization of their therapeutic potential.

Todd C Chappell, Kathleen G Maiello, Allison J Tierney, Karin Yanagi, Jessica A Lee, Kyongbum Lee, Charles R Mace, Clay S Bennett, Nikhil U Nair

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Todd C ChappellDepartment of Chemical & Biological Engineering, Tufts University, Medford, Massachusetts, USA.
Kathleen G MaielloDepartment of Chemistry, Tufts University, Medford, Massachusetts, USA.
Allison J TierneyDepartment of Chemistry, Tufts University, Medford, Massachusetts, USA.
Karin YanagiDepartment of Chemical & Biological Engineering, Tufts University, Medford, Massachusetts, USA.
Jessica A LeeDepartment of Chemical & Biological Engineering, Tufts University, Medford, Massachusetts, USA.
Kyongbum LeeDepartment of Chemical & Biological Engineering, Tufts University, Medford, Massachusetts, USA.
Charles R MaceDepartment of Chemistry, Tufts University, Medford, Massachusetts, USA.
Clay S BennettDepartment of Chemistry, Tufts University, Medford, Massachusetts, USA.
Nikhil U NairDepartment of Chemical & Biological Engineering, Tufts University, Medford, Massachusetts, USA.ORCID http://orcid.org/0000-0001-7737-1385

Funding

Developing Synthetic Enzymes to Treat Inborn Errors of MetabolismR21HD105934 · NICHD · TUFTS UNIVERSITY MEDFORD · PI NAIR, NIKHIL UNNI · 2022 to 2023
$344k
James KanagyNational Science FoundationNICHD NIH HHS R21 HD105934NIH HHS
6 · The paper itself

Abstract

Microbial-derived natural products remain a major source of structurally diverse bioactive compounds and chemical scaffolds that have the potential as new therapeutics to target drug-resistant pathogens and cancers. In particular, genome mining has revealed the vast number of cryptic or low-yield biosynthetic gene clusters in the genus Streptomyces. However, low natural product yields-improvements to which have been hindered by the lack of high throughput methods-have slowed the discovery and development of many potential therapeutics. Here, we describe our efforts to improve yields of landomycins-angucycline family polyketides under investigation as cancer therapeutics-by a genetically modified Streptomyces cyanogenus 136. After simplifying the extraction process from S. cyanogenus cultures, we identified a wavelength at which the major landomycin products are absorbed in culture extracts, which we used to systematically explore culture medium compositions to improve total landomycin titers. Through correlational analysis, we simplified the culture optimization process by identifying an alternative wavelength at which culture supernatants absorb yet is representative of total landomycin titers. Using the subsequently improved sample throughput, we explored landomycin production during the culturing process to further increase landomycin yield and reduce culture time. Testing the antimicrobial activity of the isolated landomycins, we report broad inhibition of Gram-positive bacteria, inhibition of fungi by landomycinone, and broad landomycin resistance by Gram-negative bacteria that is likely mediated by the exclusion of landomycins by the bacterial membrane. Finally, the anticancer activity of the isolated landomycins against A549 lung carcinoma cells agrees with previous reports on other cell lines that glycan chain length correlates with activity. Given the prevalence of natural products produced by Streptomyces, as well as the light-absorbing moieties common to bioactive natural products and their metabolic precursors, our method is relevant to improving the yields of other natural products of interest.

Indexed as

AminoglycosidesStreptomycesAntineoplastic AgentsHumansSpectrophotometryAminoglycosidesAntineoplastic Agentsangucyclinechemotherapeuticmedia optimizationnatural productpolyketideStreptomyces

Identifiers

PMID38686918
PMCPMC11324409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.